VOR
Vor Biopharma, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website vorbio.com
- Employees(FY) 133
- ISIN US9290331084
Performance
0.0%
1W
+5.85%
1M
-12.14%
3M
+2.84%
6M
-19.56%
YTD
-59.87%
1Y
Profile
Vor Biopharma Inc., a clinical-stage company, engages in the development of engineered hematopoietic stem cell (eHSC) therapies for cancer patients. The company is developing lead product, tremtelectogene empogeditemcel (trem-cel), formerly VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. It also offers Mylotarg, a CD33-directed antibody drug conjugate (ADC) therapy for patients with leukemia; VCAR33, a CAR-T therapy designed to target CD33, a clinically validated target for AML, currently under preclinical and Phase 1/2 clinical studies; trem-cel + VCAR33 treatment system, currently under preclinical studies for the treatment of AML; and CD33-CLL1 treatment system, made with CD33-CLL1 multiplex-engineered eHSC and CD33-CLL1 multi-specific CAR-T, currently under preclinical studies for the treatment of AML. Vor Biopharma Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Technical Analysis of VOR 2024-05-10
Overview:
In analyzing the technical indicators for VOR stock over the last 5 days, we will delve into the trends, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been fluctuating around...
Recent News & Updates
- 2024-05-12 21:22
- 2024-05-09 10:54
VOR Stock Earnings: Vor Biopharma Beats EPS for Q1 2024(Investorplace)
- 2024-05-09 04:05
- 2024-05-05 20:00
Vor Bio to Participate in Upcoming Investor Conferences(Globenewswire)
- 2024-05-03 04:01
- 2024-05-02 04:01
- 2024-04-03 20:32
- 2024-03-31 20:00
Vor Bio to Participate in Upcoming Investor Conferences(Globenewswire)
- 2024-03-20 09:53
VOR Stock Earnings: Vor Biopharma Beats EPS for Q4 2023(Investorplace)
- 2024-03-20 04:05
- 2024-03-05 03:01
- 2024-03-03 19:00
Vor Bio to Participate in Upcoming Investor Conferences(Globenewswire)
- 2024-02-15 01:56
- 2024-02-06 19:00
- 2024-02-02 03:01
- 2024-01-18 19:22
- 2024-01-17 03:01
- 2023-12-21 03:01
- 2023-12-01 03:01
- 2023-11-26 19:00
- 2023-11-09 03:01
- 2023-11-07 03:05
- 2023-11-03 04:01
- 2023-11-02 20:00
Vor Bio to Participate in Upcoming Investor Conferences(Globenewswire)
- 2023-11-01 21:01
- 2023-10-03 04:01
- 2023-09-24 20:00
Vor Bio to Participate in Upcoming Investor Conferences(Yahoo Finance)
- 2023-08-29 20:00
Vor Bio to Participate in Upcoming Investor Conferences(Yahoo Finance)
- 2023-08-10 04:05
- 2023-07-31 20:00
Page 1 of 4
previousnext